Denali Therapeutics Inc. (DNLI)
DNLIDenali Therapeutics Inc.loading…
loading…
QTick signal
-2net
2 bull / 3 bear factors · balancedBull 3 pts·Bear 5 pts30d
loading…
Market context—Sector read · not on fileOKBalance sheet · Safe—Inflation-report days · not on fileOKCalm trading · sharp-drop risk 0/100 · Nov 6
Death cross
50-day average is below the 200-day — a downtrend
Momentum (RSI)54.1fires under 35 · fires near $16.56
Price vs. profitno profit to compare
Last session traded in line with its own normal, price up 1.8%. Over the last 20 sessions, 45% of the volume traded on days the stock closed lower.
Entry strategy · 10 triggers
2 of 5 aligned — closing inRSI 14
●
54.1
fires under 35 · fires near $16.56
vs 50-day
✓
$20.16
at the line
Bollinger
●
$17.41
no lower pierce · fires near $17.16
VWAP 20
●
$19.08
above the rolling VWAP · fires near $19.06
Entry level
✓
$19.97
within 1% of model level
Put wall
●
—
not on file
MACD
Context✓
+0.28
histogram above zero · fading
RVolStatic
0.87×
in line with its own normal
Short int.Static
10.7%
short interest below 20%
ATRStatic
$0.91
14-session average true range
A checklist, not odds on a return: 3 of 5 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
2026-11-05
reported last session · reaction session open
Next dividend
No indicated yield
no forward dividend on file